Evan Siegerman, BMO biotech analyst, joins 'Power Lunch' to discuss the big winners in the pharmaceutical space in 2025.

Evan David Seigerman, BMO managing director, joins 'Fast Money' to discuss Novo sinking on its obesity drug data.

Movahedi writes that the “overarching assumption” for TD is that the bank’s U.S. retail business is not an impaired asset, ...

With a $500-million budget, the Calgary Municipal Land Corporation (CMLC) managed to deliver the BMO Centre expansion this ...

Coming off of Novo Nordisk's (NVO) sharp stock decline after its experimental weight-loss shot CagriSema was found to help recipients lose less weight than previously forecasted, BMO Capital Markets ...

The report by BMO says 30 per cent of Canadians plan to curtail their spending in 2025. The poll also says 46 per cent of ...

BMO Junior Gold Index ETF (TSE:ZJG – Get Free Report)’s share price traded down 0.7% on Tuesday . The stock traded as low as C$92.56 and last traded at C$92.56. 652 shares changed hands during mid-day ...

BMO Capital Markets upgraded TD Bank ( NYSE: TD) to Outperform from Market Perform as the valuation of the stock appears to ...

Telecom tower REIT SBA Communications (SBAC) was trading lower after BMO Capital Markets downgraded the stock on 2025 leasing ...

Bank of Montreal misses estimates as loan-loss provisions rise, while CIBC reports higher fourth-quarter profit, boosts ...

The brokerage lowered its price target on Merck (NS:PROR) to $105 and flagged a lack of near-term catalysts, suggesting the stock may remain range-bound over the next year. BMO noted that the ...

BMO says Canadians have increased concerns about the cost of living (54%), inflation (50%) and a possible economic recession ...